EUVIMEDOpdag EUVIMED
Crossref

Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers–Danlos Syndrome: A Propensity‐Matched Analysis of 118,256 Individuals

Saqr Alsakarneh, Omar Al Ta'ani iD, Mahmoud Y Madi, Wing-Kin Syn, James K Ruffle iD, Qasim Aziz, Adam D Farmer iD

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70506 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2026. Written by Saqr Alsakarneh and 6 co-authors. Institution: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Ehlers-Danlos Syndrome, Gastrointestinal Diseases. Cited 4 times so far (Crossref); 47 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Ehlers–Danlos syndrome (EDS) comprises inherited connective tissue disorders characterised by joint hypermobility, skin hyperextensibility and tissue fragility. It links to systemic comorbidities, including gastrointestinal (GI) disorders, but hitherto large‐scale data remain limited. We aimed to evaluate the prevalence of GI, systemic and psychological comorbidities in EDS patients versus propensity score‐matched controls, using a comprehensive research network database.

Design

This was a retrospective, propensity‐matched analysis (2005–2023) utilising the TriNetX network. We identified EDS patients (excluding Marfan's syndrome). Propensity score matching (1:1) generated balanced cohorts for age, sex and baseline characteristics. Comorbidities were analysed via prevalence rates and odds ratios (ORs) with 95% confidence intervals (CIs).

Results

Matched cohorts included 59,128 pairs. Among GI disorders, gastroesophageal reflux disease was most common in EDS (18.4%, OR 1.5, 95% CI 1.4–1.5, p < 0.001), followed by constipation (12.4%, OR 1.8, 95% CI 1.7–1.9, p < 0.001), irritable bowel syndrome (7.3%, OR 2.6, 95% CI 2.5–2.8, p < 0.001) and gastroparesis (4.7%, OR 8.2, 95% CI 7.3–9.2, p < 0.001). Psychiatric conditions showed heightened prevalence of anxiety (26.1%, OR 1.8, 95% CI 1.7–1.8, p < 0.001) and depression (18.7%, OR 1.3, 95% CI 1.2–1.3, p < 0.001). Systemic comorbidities included postural orthostatic tachycardia syndrome (13.2%, OR 899.7, 95% CI 483.8–1673.0, p < 0.001), chronic pain (7.9%, OR 7.0, 95% CI 6.4–7.6, p < 0.001), migraines (19.7%, OR 2.5, 95% CI 2.4–2.6, p < 0.001) and fibromyalgia (9.5%, OR 1.7, 95% CI 1.6–1.8, p < 0.001).

Conclusion

EDS patients exhibit heightened risk for GI, systemic and psychological comorbidities, highlighting the importance of multidisciplinary approaches for effective management.

Subjects

MeSH terms (MEDLINE)

Ehlers-Danlos SyndromeGastrointestinal DiseasesHumansFemaleMaleAdultRetrospective StudiesComorbidityMiddle AgedPropensity ScorePrevalenceYoung AdultAdolescentRisk Factors

Author keywords

Ehlers–Danlos syndromeGIdisorders of gut brain interaction

Authors and institutions

  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
  • Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
  • Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Bilbao, Spain.
  • Queen Square Institute of Neurology, University College London, London, UK.
  • Wingate Institute of Neurogastroenterology, Queen Mary University of London, London, UK.

ORCID profiles: Omar Al Ta'ani, James K Ruffle, Adam D Farmer

Cite

APA

Alsakarneh, S., Al Ta'ani, O., Madi, M. Y., Syn, W. K., Ruffle, J. K., Aziz, Q., & Farmer, A. D. (2026). Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers–Danlos Syndrome: A Propensity‐Matched Analysis of 118,256 Individuals. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70506

Vancouver

Alsakarneh S, Al Ta'ani O, Madi MY, Syn WK, Ruffle JK, Aziz Q, et al. Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers–Danlos Syndrome: A Propensity‐Matched Analysis of 118,256 Individuals. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70506

BibTeX
@article{Alsakarneh2026,
  author = {Alsakarneh, Saqr and Al Ta'ani, Omar and Madi, Mahmoud Y and Syn, Wing-Kin and Ruffle, James K and Aziz, Qasim and Farmer, Adam D},
  title = {Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers–Danlos Syndrome: A Propensity‐Matched Analysis of 118,256 Individuals},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70506}
}
Start for free →